Paradigm Capital Management Inc. NY Takes $4.07 Million Position in Accendra Health, Inc. $ACH

Paradigm Capital Management Inc. NY bought a new position in shares of Accendra Health, Inc. (NYSE:ACH) during the 1st quarter, HoldingsChannel.com reports. The fund bought 1,786,400 shares of the company’s stock, valued at approximately $4,073,000.

Other hedge funds have also bought and sold shares of the company. Dimensional Fund Advisors LP acquired a new position in Accendra Health during the 1st quarter valued at approximately $5,943,000. Bank of New York Mellon Corp acquired a new stake in shares of Accendra Health during the first quarter worth $592,000. Strs Ohio acquired a new stake in shares of Accendra Health during the first quarter worth $413,000. State of Wyoming acquired a new stake in shares of Accendra Health during the first quarter worth $385,000. Finally, Allspring Global Investments Holdings LLC purchased a new stake in shares of Accendra Health during the first quarter valued at $239,000.

Wall Street Analysts Forecast Growth

Several equities analysts recently issued reports on ACH shares. Weiss Ratings raised Accendra Health from a “sell (e+)” rating to a “sell (d-)” rating in a research report on Tuesday. Robert W. Baird lifted their price target on Accendra Health from $5.00 to $6.00 and gave the stock an “outperform” rating in a research report on Tuesday, May 12th. Zacks Research upgraded Accendra Health from a “strong sell” rating to a “hold” rating in a research note on Tuesday, April 21st. Citigroup cut their price objective on Accendra Health from $5.00 to $4.50 and set a “buy” rating on the stock in a report on Friday. Finally, UBS Group raised their price objective on Accendra Health from $3.00 to $4.50 and gave the stock a “neutral” rating in a research note on Tuesday, May 12th. Two equities research analysts have rated the stock with a Buy rating, two have issued a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Hold” and an average target price of $5.00.

Accendra Health Price Performance

NYSE ACH opened at $3.13 on Friday. The firm has a market capitalization of $239.70 million, a P/E ratio of -0.22, a PEG ratio of 4.82 and a beta of 1.58. The firm’s fifty day simple moving average is $3.12. Accendra Health, Inc. has a 1 year low of $1.84 and a 1 year high of $7.99.

Accendra Health (NYSE:ACH) last announced its quarterly earnings results on Monday, May 11th. The company reported ($0.04) earnings per share for the quarter, topping the consensus estimate of ($0.06) by $0.02. The company had revenue of $627.78 million for the quarter. Accendra Health had a negative return on equity of 13.18% and a negative net margin of 39.84%. As a group, equities analysts predict that Accendra Health, Inc. will post 0.31 earnings per share for the current year.

Accendra Health Company Profile

Accendra Health Inc is a nationwide provider of products, technology, and services that support health beyond the hospital by connecting patients, providers, and insurers. Through its brands, Apria and Byram Healthcare, the company delivers disposable medical supplies, integrated home healthcare equipment, and related services that help improve health outcomes and quality of life for individuals with chronic, complex, and acute health conditions. Its offerings span diabetes treatment, home respiratory therapy, and obstructive sleep apnea treatment, along with patient support services.